Synthesis and Cytotoxic Activity of Novel 5-Substituted-1-(β-L-Arabinofuranosyl) Pyrimidine Nucleosides

A series of new 5-halogeno-1-(ß-L-arabinofuranosyl)uracils and their cytosine analogues were synthesized by halogenation of ara-L-uridine and ara-L-cytidine, respectively. The 5-(2-thienyl) and 5-halogenothienyl derivatives of both series were also prepared in excellent yields by Stille coupling followed by halogenation. All of these syntheses were based on benzoyl-protected derivatives. In vitro cytotoxicity experiments carried out using L1210 mouse leukemia cells showed that 5-(2-thienyl)-ara-L-uridine was the most potent compound of the new compounds; the majority of the analogues were not effective up to 200 μM concentrations.

[1]  K. Liliom,et al.  Nucleotide promiscuity of 3-phosphoglycerate kinase is in focus: implications for the design of better anti-HIV analogues. , 2011, Molecular bioSystems.

[2]  David V Glidden,et al.  Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. , 2010, The New England journal of medicine.

[3]  A. Muroyama,et al.  Highly Efficient Method for C-5 Halogenation of Pyrimidine-Based Nucleosides in Ionic Liquids , 2009 .

[4]  S. Malhotra,et al.  Ionic Liquid Mediated Synthesis of 5-Halouracil Nucleosides: Key Precursors for Potential Antiviral Drugs , 2009, Nucleosides, nucleotides & nucleic acids.

[5]  R. Swords,et al.  Troxacitabine in acute leukemia , 2007, Hematology.

[6]  Todd C Appleby,et al.  Hepatitis C Virus Therapies: Current Treatments, Targets and Future Perspectives , 2003, Antiviral chemistry & chemotherapy.

[7]  R. Harvey,et al.  Potent and Selective Inhibition of Human Cytomegalovirus Replication by 1263W94, a Benzimidazole l-Riboside with a Unique Mode of Action , 2002, Antimicrobial Agents and Chemotherapy.

[8]  J. Balzarini,et al.  Stereospecific Synthesis and Biological Evaluations of β‐L‐Pentofuranonucleoside Derivatives of 5‐Fluorouracil and 5‐Fluorocytosine. , 2001 .

[9]  E. De Clercq,et al.  Stereospecific synthesis and biological evaluations of beta-L-pentofuranonucleoside derivatives of 5-fluorouracil and 5-fluorocytosine. , 2001, European journal of medicinal chemistry.

[10]  Y. Cheng,et al.  Anticancer activity of beta-L-dioxolane-cytidine, a novel nucleoside analogue with the unnatural L configuration. , 1995, Cancer research.

[11]  Rakesh Kumar,et al.  A mild and efficient methodology for the synthesis of 5-halogeno uracil nucleosides that occurs via a 5-halogeno-6-azido-5,6-dihydro intermediate , 1994 .

[12]  Tai-shun Lin,et al.  Synthesis of 1-β-L-Arabinofuranosylcytosine (β-L-Ara-C) and 2′-Deoxy-2′-methylene-β-L-cytidine (β-L-DMDC) as Potential Antineoplastic Agents , 1994 .

[13]  E. De Clercq,et al.  Synthesis and antiviral activity of 5-thien-2-yl-2'-deoxyuridine analogues. , 1993, Journal of medicinal chemistry.

[14]  R. Schinazi,et al.  L-beta-(2S,4S)- and L-alpha-(2S,4R)-dioxolanyl nucleosides as potential anti-HIV agents: asymmetric synthesis and structure-activity relationships. , 1993, Journal of medicinal chemistry.

[15]  R F Schinazi,et al.  Selective inhibition of human immunodeficiency viruses by racemates and enantiomers of cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine , 1992, Antimicrobial Agents and Chemotherapy.

[16]  R. Schinazi,et al.  Activities of the four optical isomers of 2',3'-dideoxy-3'-thiacytidine (BCH-189) against human immunodeficiency virus type 1 in human lymphocytes , 1992, Antimicrobial Agents and Chemotherapy.

[17]  E. De Clercq,et al.  5-(5-Bromothien-2-yl)-2'-deoxyuridine and 5-(5-chlorothien-2-yl)-2'-deoxyuridine are equipotent to (E)-5-(2-bromovinyl)-2'-deoxyuridine in the inhibition of herpes simplex virus type I replication. , 1991, Journal of medicinal chemistry.

[18]  M. Robins,et al.  Cerium(IV)-Mediated Halogenation at C-5 of Uracil Derivatives. , 1991 .

[19]  E. De Clercq,et al.  Regeneration of the antiviral drug (E)-5-(2-bromovinyl)-2'-deoxyuridine in vivo. , 1984, Nucleic acids research.

[20]  W. Sung Synthesis of 4-(1,2,4-triazol-1-yl)-pyrimidin-2(1H)-one ribonucleotide and its application in synthesis of oligoribonucleotides , 1982 .

[21]  M. Maccoss,et al.  New procedure for the chlorination of pyrimidine and purine nucleosides , 1981 .

[22]  A. Hoshi,et al.  Pyrimidine nucleosides. 5. Syntheses of carcinostatic halogenocyclonucleosides. , 1972, Journal of medicinal chemistry.

[23]  A. Holý Nucleic acid components and their analogues. CLIII. Preparation of 2'-deoxy-L-ribonucleosides of the pyrimidine series , 1972 .

[24]  F. Šorm,et al.  Nucleic acids components and their analogues. LIII. Preparation of 1-2'-deoxy-β-L-ribofuranosylthymine, L-thymidine , 1964 .

[25]  T. Slater,et al.  STUDIES ON SUCCINATE-TETRAZOLIUM REDUCTASE SYSTEMS. III. POINTS OF COUPLING OF FOUR DIFFERENT TETRAZOLIUM SALTS. , 1963, Biochimica et biophysica acta.

[26]  J. Fox,et al.  Pyrimidine nucleosides. , 1959, Advances in carbohydrate chemistry.